About Us
Our Company

Board Of Directors

Our Workplace

Our Partners

…we value life.
Our services are focused on the commitment to providing a better life for all people. Our array of products, how we manufacture them, and how we interact with society – preserve our mantra.
Our Products
Adding value.
We are fully invested in promoting a better life for all people, and this reflects in the way we manufacture and present our affordable products.

Products

Registered Distributors

Pharmaceuticals
Your Health
Fidson Healthcare Plc is dedicated to providing the latest and most accurate information on health conditions, enabling individuals to make informed decisions for their well-being.
We are dedicated to providing the latest and most accurate information on health conditions, enabling individuals to make informed decisions for their well-being.
At Fidson, we value life

Diseases & Conditions

Cancer

Cold and Flu

Diabetes

Eye And Ear Care

Healthy Living

Antibiotics

Brain And Nervous System

Digestive Health

Immune System

Managing Your Health

Evaluating Health Information

Health Literacy

Wellness
Investors
Shareholder Information

Corporate Governance

Financial Reports

Find out the latest information on our financial performance, corporation governance and plans for the future.
News & Media
See what we have been up to

Keep up to date with our news and recent announcements

Products Announcements

Events

Press Releases
Responsibility
Corporate Social Responsibility

Health, Safety, and Environment

Quality Policy

We believe that our business endeavors should have a positive effect on the environment and society as a whole.
Contact

MOXIFLOXACIN

September 27, 2022

Fluoroquinolone

Active Ingredient: Moxifloxacin 0.5%

Indication:
Purulent bacterial conjunctivitis caused by moxifloxacin susceptible strains.

Latest News

Fidson holds Signing Ceremony to commence Rights Issue for N21billion to Fortify Market Dominance

Fidson Healthcare Plc, Nigeria’s leading pharmaceutical manufacturer, on Friday, December...

December 12, 2025

FIDSON APPOINTS TWO NEW FEMALE INDEPENDENT NON-EXECUTIVE DIRECTORS

Nigeria’s leading pharmaceutical company, Fidson Healthcare Plc announces the appointment...

November 21, 2025

Fidson Signs MOU with Japanese Firm at TICAD9

In a significant move set to transform Africa’s healthcare landscape,...

September 3, 2025

Fidson Founder Dr. Ayebae Retires, Appoints Biola Adebayo as New MD/CEO.

Shareholders Approve N1.00 Dividend per 50 kobo ordinary shares and...

August 2, 2025

Continue Reading

MOXIFLOXACIN

Fluoroquinolone Active Ingredient: Moxifloxacin 0.5% Indication: Purulent bacterial conjunctivitis caused by moxifloxacin susceptible strains.

September 27, 2022 No Comments

268, Ikorodu Road, Obanikoro P. O. Box 7210, Shomolu, Lagos, Nigeria

…we value life.

Adding value.

At Fidson, we value life

See what we have been up to

MOXIFLOXACIN

MOXIFLOXACIN

Latest News

Continue Reading

RELATED POSTS

MOXIFLOXACIN